Cocaine Use: Recommendations in Treatment and Rehabilitation

Selected References

Addictions Foundation of Manitoba (1995). RNYIS Project Evaluation. Winnipeg, Manitoba.

Adlaf, E., Paglia, A. & Iris, F.J. (1999). Drug Use Among Ontario Students. Findings from the OSDUS 1977-1999, Toronto, Centre for Addiction and Mental Health.

Agosti, V., Nunes, E., & Ocepeck-Welikson, K. (1996). Patient factors related to early attrition from an outpatient cocaine research clinic. American Journal of Drug & Alcohol Abuse, 22, 29-39.

Alberta Alcohol & Drug Commission. (1997). Substance Use among Alberta Adolescents: Prevalence & Related Factors. Edmonton: Alberta.

Alterman, A.I., Droba, M., Antelo, R.E., Cornish, J.W., Sweeney, K.K., Parikh, G.A., & O'Brien, C.P. (1992). Amantadine may facilitate detoxification of cocaine addicts. Drug & Alcohol Dependence, 31, 19-29.

Alterman, A.I., O'Brien, C.P., &. Droba, M. (1996). Day hospital vs. inpatient rehabilitation of cocaine abusers: An interim report. NIDA Research Monograph, 163, 150-162.

Angelilli, M.L., Fischer, H., Delaney-Black, V., Rubenstein, M., Ager, J.W., & Sokol, R.J. (1994). History of in utero cocaine exposure in language-delayed children. Clinical Pediatrics, 514-516.

Anthony, J.C. & Petronis, K.R. (1993). Epidemiologic evidence on suspected associations between cocaine use & psychiatric disturbances. NIDA Research Monograph. 71-94.

Anthony, J.C., Vlahov, D., Nelson, K., Cohn, S., & Solomon, L. (1991). Evidence on intravenous cocaine use & the risk of infection with human immunodeficiency virus type 1. American Journal of Epidemiology, 134(10), 1175-1189.

Archibald, C.P., Ofner, M., Strathdee, S.A., Patrick, D.M., Sutherland, D., Rekart, M.L., Schechter, M.T., & Oshaughnessy, M.V. (1998). Factors associated with frequent needle exchange program attendance in people who inject drugs in Vancouver, Canada. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 17, 160-166.

Azrin, N.H., McMahon, P.T., Donohue, B., Besalel, V.A., Lapinski, K.J., Kogan, E.S., Acierno, R.E., & Galloway, E. (1994). Behavior therapy for drug abuse: A controlled treatment outcome study. Behavioral Research & Therapy, 32(8), 857-866.

Bailey, B.J. (1996). Looking back at a century of cocaine-use & abuse. Laryngoscope, 106, 680-683.

Bailey, G.W. (1989). Current perspectives on substance abuse in youth. Journal of American Academic Child Adolescent Psychiatry, 28(2), 151-162.

Ball, S.A., Carroll, K.M., Babor, T.F., & Rounsaville, B.J. (1995). Subtypes of cocaine abusers: Support for a Type A-Type B distinction. Journal of Consulting & Clinical Psychology, 63, 115-124.

Balshem, M., Oxman, G., van Rooyen, D., & Girod, K. (1992). Syphilis, sex, & crack cocaine: Images of risk & morality. Social Science Medicine, 35(2), 147-160.

Barber, J.P., Frank, A., Weiss, R.D., Blaine, J., Siquel&, L., Moras, K., Calvo, N., Chittams, J., Mercer, D., & Salloum, I.M. (1996). Prevalence & correlates of personality disorder diagnoses among cocaine dependent outpatients. Journal of Personality Disorders, 10, 297-311.

Batki, S.L., Washburn, A., Manfredi, J., Murphy, J., Herbst, M.D., Delucci, K., Jones, T., Nand, N., Jacob, P., & Jones, R.T. (1994). Fluoxetine in primary & secondary cocaine dependence: Outcome using quantitative benzoylecgonine concentration. In L S. Harris, (Ed.) Problems of Drug Dependence, 1993: Proceedings of the 55th Annual Scientific Meeting; The College on Problems of Drug Dependence Inc., National Institute of Drug Abuse Monograph 141, NIH Pub. No. 94-3749, Washington, D.C., Supt. of Docs., U.S. Govt. Print. Off. 1994, p.140.

Batki, S.L., Washburn, A.M., Delucchi, K., & Jones. R.T. (1996). A controlled trial of fluoxetine in crack cocaine dependence. Drug & Alcohol Dependence, 41, 137-142.

Bell, D.C., Richard, A.J., & Feltz, L.C. (1996). Mediators of drug treatment outcomes. Addictive Behaviors, 21(5), 597-613.

Benowitz, N.L. (1992). How toxic is cocaine? Cocaine: Scientific & Social Dimensions, John Wiley & Sons: Chichester, 125-143.

Biebuyck, J. (1990). Pharmacology & therapeutic applications of cocaine. Anesthesiology, 73(3), 518-531.

Blanchard, J. & Elliot, L. (1998). Summary of Interim Results from the Winnipeg Injection Drug Epidemiology (WIDE) Study. Manitoba Health Epidemiology Unit.

Blank-Reid, C. (1996). How to have a stroke at an early age: The effects of crack, cocaine & other illicit drugs. Journal of Neuroscience Nursing, 28(1), 19-27.

Brady, K.T., Sonne, S., Randall, C.L., Adinoff, B., & Malcolm, R. (1995). Features of cocaine dependence with concurrent alcohol abuse. Drug & Alcohol Dependence, 39, 69-71.

Brands, B., Sproule, B. & Marshman, J.,( Eds.) (1998). Drugs & Drug Abuse: A Reference Text, 3rd edition. Toronto: Addiction Research Foundation.

Brown, T.G., Seraganian, P., & Tremblay, J. (1993). Alcohol & cocaine abusers six months after traditional treatment: Do they fare as well as problem drinkers? Journal of Substance Abuse Treatment, 10, 545-552.

Brown, T.G., Seraganian, P., & Tremblay, J. (1994). Alcoholics also dependent on cocaine & treatment: Do they differ from "pure" alcoholics? Addictive Behaviors, 19(1), 105-112.

Bruneau, J., Lamothe, F., Franco, E., Lachance N., Desy, M., Soto, J., & Vincelette, J. (1997). High rates of HIV infection among people who inject drugs participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology, 146, 994-1002.

Burton, R.P.D., Johnson, R.J., Ritter, C., & Clayton, R.R. (1996). The effects of role socialization on the initiation of cocaine use: An event history analysis from adolescence into middle adulthood. Journal of Health & Social Behavior, 37, 75-90.

Buydens-Branchey, L., Branchey, M., Fergeson, P., Hudson, J., & McKernin, C. (1997). The meta-chlorophenylpiperazine challenge test in cocaine addicts: Hormonal & psychological responses. Biological Psychiatry, 41, 1071-1086.

Bystritsky, A., Ackerman, D.L, & Pasnau, R.O. (1991). Low dose desipramine treatment of cocaine-related panic attacks. Journal of Nervous & Mental Disease, 179(12), 755-758.

Campbell, J.L., Thomas, H.M., Gabrielli, W., Liskow, B.I., & Powell, B. J. (1994). Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: Preliminary findings. Journal of Addictive Diseases, 13, 191-199.

Canadian Centre on Substance Abuse & Canadian Public Health Association. (1997). National Task Force on HIV, AIDS & Injection Drug Use. HIV, AIDS, & injection drug use: a national action plan. Ottawa: Health Canada.

Cardoso, F. & Jankovic, J. (1993). Movement disorders. Neurologic Complications of Drug & Alcohol Abuse, 11(3), 625-638.

Carroll, K.M. (1996). Relapse Prevention as a Psychosocial Treatment Approach: A Review of Controlled Clinical Trials. Experimental. Clinical Psychopharmacology, 4, 46-54.

Caroll, K.M., Rounsavile, B.J., Gawin, Frank H. (1991). A comparative Trial of Psychotherapies for Ambulatory Cocaine Abusers: Relapse Prevention and Interpersonal Psychotherapy, American Journal of Drugs and Alcohol Abuse, 17(3), 229-247.

Carroll, K.M., Nich, C., Ball, S.A., McCane, E., & Rounsaville, B.J., (1998). Treatment of cocaine & alcohol dependence with psychotherapy & disulfirm. Addiction, 93(5) 713-728.

Carroll, K.M., Rounsaville, B.J., Gordon, L.T., Nich, C., Jatlow, P., Bisighini, R.M., Gawin, F.J. (1994a) , Psychotherapy & Pharmacotherapy for Ambulatory Cocaine Users. Archives of General Psychiatry, 51, 177-187.

Carroll, K.M., Rounsaville, B.J., Nich, C., Gordon, L.T., Wirtz, P.W., & Gawin, F. (1994b). One-year follow-up of psychotherapy & pharmacotherapy for cocaine dependence. Archives of General Psychiatry, 51, 989-997.

Chaisson, R., Bacchetti, P., Osmond, D., Brodie, B., Sand, M. & Moss A. (1989). Cocaine use & HIV infection in intravenous drug users in San Francisco. JAMA, 26(10), 561-565.

Chen, K., Scheier, L.M.,& Kandel, D.B. (1996). Effects of chronic cocaine use on physical health: a prospective study in a general population sample. Drug & Alcohol Dependence, 43, 23-37.

Cheung, Y.W., Erickson, P.G., & Landau, T.C. (1991). Experience of crack use: Findings from a community-based sample in Toronto. Journal of Drug Issues, 21, 121-140.

Chrtis-Christoph, P., Siqueland, L., Blaine, J., Frank, A. Luborksy, L. Onken. L., , Muenz, L.R., Thase, M.E., Weiss, R.D., Gastfriend, D.R., Woods, G.E., Barber, J.P., Butler, S.F., Daley, D., Salloum, I., Bishop, S., Najavits, L.M., Lis, J., Mercer, D., Griffin, M.L., Moras, K. & Beck, A.T., (1999). Psychosocial Treatments for Cocaine Dependence. Archives of General Psychiatry, 56, 493-502.

Compton, W.M., Lamb, R.J., & Fletcher, B.W. (1995). Results of the NIDA treatment demonstration grants' cocaine workgroup: Characteristics of cocaine users & HIV risk behaviors. Drug & Alcohol Dependence, 37, 1-6.

Condelli, W.S., Fairbank, J.A., Dennis, M.L., & Rachal, J.V. (1991). Cocaine use by clients in methadone programs: Significance, scope, & behavioral interventions. Journal of Substance Abuse Treatment, 8, 203-212.

Cornish, J.W., Maany, I., Fudala, P.J., Neal, S., Poole, S.A., Volpicelli, P. & O'Brien, C.P. (1995).

Carbamazepine treatment for cocaine dependence. Drug & Alcohol Dependence, 38, 221-227.

Covi, L., Hess, J.M., Kreiter, N.A., & Haertzen, C.A. (1995). Effects of combined fluoxetine & counseling in the outpatient treatment of cocaine abusers. American Journal of Drug & Alcohol Abuse, 21, 327-344.

Crum, R.M. & Anthony, J.C. (1993). Cocaine use & other suspected risk factors for obsessive-compulsive disorder: A prospective study with data from the Epidemiologic Catchment Area Surveys. Drug and Alcohol Dependence, 31, 281-295.

Das, G. (1993). Cocaine abuse in North America: A milestone in history. Journal of Clinical Pharmacology, 33, 296-310.

Dhossche, D. & Rubinstein, J. (1996). Drug detection in a suburban psychiatric emergency room. Annals of Clinical Psychiatry, 8(2), 59-69.

Di Paolo, N., Fineschi, V., Di Paolo, M., Wetly, C.V., Garosi, G., Del Vecchio, M.T., & Bianciardi, G. (1997). Kidney vascular damage & cocaine. Clinical Nephrology, 47(5), 298-303.

Egelko, S., Galanter, M., Edwards, H. & Marinelli, K. (1996). Treatment of perinatal cocaine addiction: use of the modified therapeutic community. American Journal of Drug Alcohol Abuse, 22, 185-202.

Eiler, K., Schaefer, M.R., Salstrom, D., & Lowery, R. (1995). Double-blind comparison of bromocriptine & placebo in cocaine withdrawal. American Journal of Drug & Alcohol Abuse, 21, 65-79.

Eissenberg, T., Johnson, R.E., Bigelow, G.E., Walsh, S.L., Liebson, I.A., Strain, E.C., & Stitzer, M.L. (1997). Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients. Drug & Alcohol Dependence, 45, 81-91.

Elangovan, N., Barbato, M., Cooper, T., & Winsberg, B. (1996). Neurohormonal & behavioral response to methylphenidate in cocaine abstinence. Psychiatry Research, 65, 65-71.

Elk, R., Schmitz, J., Spiga, R., Rhoades, H., Andres, R., & Grabowski, J. (1995). Behavioral treatment of cocaine-dependent pregnant women & TB-exposed patients. Addictive Behaviors, 20(4), 533-542.

Fetters, L. & Tronick, E.Z. (1996). Neuromotor development of cocaine-exposed & control infants from birth through 15 months: Poor & poorer performance. Pediatrics, 98(5), 938-943.

Fineschi, V., Wetli, C.V., Di Paolo, M., & Baroldi, G. (1997). Myocardio neurosis & cocaine: A quantitative morphologic study in 26 cocaine-associated deaths. International Journal of Legal Medicine, 110, 193-198.

Fleming, J.A., Byck, R., & Barash, P.G. (1990). Pharmacology & therapeutic applications of cocaine. Anesthesiology, 73, 518-531.

Flowers, Q., Elder, E., Voris, J., & Paxedes, S. (1993). Daily cocaine craving in a 3 week inpatient program. Journal of Clinical Psychology, 49 (2), 292-297.

Galloway, G.P., Newmeyer, J., Knapp, T., Stalcup, S.A., Smith, D. (1994). Imipramine for the treament of cocaine & methamphetamine dependence. Journal of Addictive Disease, 13(4), 201-216.

Gawin, F.H., Kieber, H.D., Byck, R., Rounsaville, B.J., Kosten, T.R., Jatlow, P.I. & Morgan, C. (1989). Desipramine Facilitation of Initial Cocaine Abstinence. Archives of General Psychiatry, 46, 117-121.

Geracioti, Jr., T.D., & Post, R.M. (1991). Onset of panic disorder associated with rare use of cocaine. Biological Psychiatry, 29, 403-406.

Gfellner, B.M. & Hundleby, J.D. (1995). Patterns of drug use among native & white adolescents: 1990-1993. Canadian Journal of Public Health, 86(2), 95-97.

Gfoerer, J., Wright, D., & Kopstein, A. (1997). Prevalence of youth substance use: The impact of methodological differences between two nation surveys. Drug & Alcohol Dependence, 47, 19-30.

Giannini, A.J., Loiselle, R.H., Graham, B.H. & Folts, D.J. (1993). Behavioral response to buspirone in cocaine & phencyclidine withdrawal. Journal of Substance Abuse Treatment, 10, 523-527.

Gingras, J.L., Feibel, J.B., Dalley, L.B., Muelenaer, A., & Knight, C.G. (1995). Maternal polydrug use including cocaine & postnatal infant sleep architecture: Preliminary observations & implications for respiratory control & behavior. Early Human Development, 43, 197-204.

Gorelick, D.A. (1992). Pathophysiological effects of cocaine in humans: Journal of Addictive Diseases, 11(4), 97-110.

Gourgoutis, G. & Das, G. (1994). Gastrointestinal manifestations of cocaine addiction. International Journal of Clinical Pharmacology & Therapeutics, 32, 136-141.

Grella, C.E., Anglin, M.D., & Wugalter, S.E. (1995). Cocaine & crack use & HIV risk behaviors among high-risk methadone maintenance clients. Drug & Alcohol Dependence, 37, 15-21.

Guadagnino, V., Zimatore, G., Izzi, A., Caroleo, B., Rocca, A., Montesano, F., Costa, C., Masciari, R., Naso, E., Biselli, R., Ippolito, G., & D'Amelio, R. (1995). Relevance of intravenous cocaine use in relation to prevalence of HIV, Hepatitis B & C virus markers among intravenous drug abusers in southern Italy. Journal of Clinical Laboratory Immunology 47, 1-9.

Guydish, J., Bucardo, M.D., Clark, G. & Bernheim, S. (1998). Evaluating needle exchange: A description of client characteristics, health status, program utilization, & HIV risk behavior. Substance Use & Misuse, 33, 1173-1196.

Haberman, P.W., Noble, J.A., & Dufour, M.C. (1995). Alcohol use in combination with cocaine, heroin, & methadone by medical examiner cases. Journal of Studies on Alcohol, 56, 344-347.

Halikas, J.A., Nugent, S.M., Crosby, R.D., & Carlson, G.A. (1993). 1990-91 Survey of pharmacotherapies used in the treatment of cocaine abuse. Journal of Addictive Diseases, 12, 129-139.

Hall, W.C., Talbert, R.L., & Ereshefsky, L. (1990). Cocaine abuse & its treatment. Pharmacotherapy, 10(1), 47-65.

Hammersley, R., Lavelle, T.L., & Forsyth, A.J.M. (1992). Adolescent drug use, health & personality. Drug & Alcohol Dependence, 31, 91-99.

Handelsman, L., Limpitlaw, L., Williams, D., Schmeidler, J., Paris, P., & Stimmel, B. (1995). Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients. Drug & Alcohol Dependence, 39, 173-180.

Hankins, C.A. (1998). Syringe exchange in Canada: good but not enough to stem the HIV tide. Substance Use & Misuse, 33, 1129-1146.

Hartgers, C., Buning, E., Van Santen, G., Verster, A., & Coutinho, R. (1989). The impact of needle & syringe exchange programme in Amsterdam on injection risk behavior. AIDS, 3, 571-576.

Hartgers, C., Van Ameijden, E., Van Den Hoek, J., & Coutinho, R. (1992). Needle sharing & participation in Amsterdam syringe exchange among HIV-negative people who inject drugs. Public Health Report, 107, 675-681.

Health Canada (2000). HIV/AIDS Among Injection Drug Users in Canada. HIV/AIDS EPI Update, Laboratory Centre for Disease Control.

Health Canada (1999). Best Practices - Substance Abuse Treatment and Rehabilitation, Ottawa, Minister of Public Works and Government Services. Cat. #H39-438/1998E

Health Promotion Institute. University of British Columbia. (1995). School-based Prevention Project. 1994-1995 Evaluation. Vancouver, British Columbia.

Heffelfinger, A., Craft, S., & Shyken, J. (1997). Visual attention in children with prenatal cocaine exposure. Journal of the International Neuropsychological Society, 3, 237-245.

Hegarty, A.M., Lipton, R.B., Merriam, A.E., & Freeman, K. (1991). Cocaine as a risk factor for acute dystonic reactions. Neurology, 41, 1670-1672.

Henderson, D., Boyd, C., & Whitmarsh, J. (1995). Women & illicit drugs: sexuality & crack cocaine. Health Care for Women International, 16, 113-124.

Higgins, S.T., Budney, A.J., Bickel, W.K., Badger, G.J., Foerg, F.E., & Ogden, D. (1995). Outpatient behavorial treatment for cocaine dependence: One year outcome. Experimental & Clinical Psychopharmacology, 3(2), 205-212.

Higgins, S.T., Budney, A.J., Bickel, W.K., & Badger, G.J., (1994a). Participation of Significant Others in Outpatient Behavioural Treatment Predicts Greater Cocaine Abstinence. American Journal of Drug and Alcohol Abuse, 20(1/2), 47-56.

Higgins, S.T., Budney, A.J., Bickel, W.K., Foerg, F.E., Donham, R., & Badger, G.J. (1994b). Incentives improve outcome in outpatient behavioral treament of cocaine dependence. Archives of General Psychiatry, 51, 568-576.

Higgins, S.T., Budney, A.J., Bickel, W.K., Hughes, J.R., Foerg, F., & Badger, G. (1993). Achieving cocaine abstinence with the behavioral approach. American Journal of Psychiatry, 150(5), 763-769.

Higgins, S.T. (1996). Some potential contributions of reinforcement & consumer-demand theory to reducing cocaine use. Addictive Behaviors, 21, 803-816.

Hitchcock, H.C., Stainback, R.D., & Roque, G.M. (1995). Effects of halfway house placement on retention of patients in substance abuse aftercare. American Journal of Drug & Alcohol Abuse, 21, 379-390.

Hoffman, J.A., Caudill, B.D., Koman III, J.J., Luckey, J.W., Flynn, P.M., & Mayo, D.W. (1996). Psychosocial treatments for cocaine abuse. 12-month treatment outcomes. Journal of Substance Abuse Treatment, 13, 3-11.

Hoffman, J.A., Eckert, M.A., Koman III, J.J., & Mayo, D.W. (1996). Profiles of clients in government-funded drug user treatment settings. Substance Use & Misuse, 31, 453-477.

Hollander, E., Nunes, E., DeCaria, C.M., Quitkin, F.M., Cooper, T., Wager, S., Klein, D.F. (1990). Dopaminergic sensitivity & cocaine abuse: Response to apomorphine. Psychiatric Research, 33, 161-169.

Howard, J., Beckwith, L., Espinosa, M., & Tyler, R. (1995). Development of infants born to cocaine-abusing women: Biologic/maternal influences. Neurotoxicology & Teratology, 17, 403-411. Hudgins, R., McCusker, J., & Stoddard, A. (1995). Cocaine use & risky injection & sexual behaviors. Drug & Alcohol Dependence, 37, 7-14.

Hughes, P.H., Coletti, S.D., Neri, R.L., Urmann,C.F., Sicilian, D.M., Stahl, S.S. & Anthony, J.C., (1994). Retention of Cocaine-abusing Women in Residential Treatment. In L.S. Harris, (Ed.) Problems of Drug Dependence, 1993: Proceedings of the 55th Annual Scientific Meeting; The College on Problems of Drug Dependence Inc., National Institute of Drug Abuse Monograph 141, NIH Pub. No. 94-3749, Washington, D.C., Supt. of Docs., U.S. Govt. Print. Off. 1994, p.4.

Inciardi, J.A. (1995). Crack, crack house sex, & HIV risk. Archives of Sexual Behavior, 24(3), 249-269.

Inciardi, J.A., McBride, D.C., McCoy H V., & Chitwood, D. (1994). Recent research on crack/cocaine/crime connection. Studies on Crime & Crime Prevention 3(1), 63-83.

Irwin, K.L., Edlin, B.R., Faruque, S., McCoy, H.V., Word, C., Serrano, Y., Inciardi, J., Bowser, B., & Holmberg, S.D. (1996). Crack cocaine smokers who turn to drug injection: Characteristics, factors associated with injection, & implications for HIV transmission. Drug & Alcohol Dependence, 42, 85-92.

Javaid, J.I., Notorangelo, M.P., Pandey, S.C., Reddy, P.L., Pandey, G.N., & Davis, J.M. (1994). Peripheral benzodiazepine receptors are decreased during cocaine withdrawal in humans. Biological Psychiatry, 36, 44-50.

Joe, G.W., & Simpson, D.D. (1995). HIV risk, gender, & cocaine use among opiate users. Drug & Alcohol Dependence, 37, 23-28.

Jonnes, J. (1995). The rise of the modern addict. American Journal of Public Health, 85(8), 1157-1162.

Kane, D.J., Aronson, R.A., & Zotti, M.E. (1997). The long-term effect of cocaine use during pregnancy-reasons for hope. Wisconsin Medical Journal, February, 37-40.

Kearney, M.H., Murphy, S., & Rosenbaum, M. (1994). Learning by losing: Sex & fertility on crack cocaine. Qualitative Health Research, 4(2), 142-162.

Kenner, C., & D'Apolito, K. (1997). Outcomes for children exposed to drugs in utero. JOGNN, 26(5), 595-603.

Khalsa, M.E., Paredes, A., Anglin, M.D., Potepan, P., & Potter, C. (1996). Combinations of treatment modalities & therapeutic outcome for cocaine dependence. NIDA Research Monograph, 163, 237-258.

Kosten, T.R., Gawin, F.H., Morgan, C., Nelson, J.C., & Jatlow, P. (1990). Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse. American Journal of Drug & Alcohol Abuse, 16, 329-336.

Kowatch, R.A., Schnoll, S.S., Knisely, J.S., Green, D., & Elswick, R.K. (1992). Electroencephalographic sleep & mood during cocaine withdrawal. Journal of Addictive Diseases, 1992; 11(4), 21-45.

Kranzler, H.R., Bauer, L.O., Hersh, D., & Klinghoffer, V. (1995). Carbamazepine treatment of cocaine dependence: A placebo-controlled trial. Drug & Alcohol Dependence, 38, 203-211.

Lam, J.A., Jekel, J.F., Thompson, K S., Leaf, P.J., Hartwell, S. W., & Florio, L. (1995). Assessing the value of a short-term residential drug treatment program for homeless men. Journal of Addictive Disease, 14(4), 21-39.

Latkin, C., Mandell, W., Oziemkowska, M., Celentano, D., Vlahov, D., Ensminger, M., & Knowlton, A. (1995). Using social network analysis to study patterns of drug use among urban users at high risk for HIV/AIDS. Drug & Alcohol Dependence, 38, 1-9.

Latkin, C.A., Mandell, W., & Vlahov, D. (1996). The relationship between risk networks' patterns of crack cocaine & alcohol consumption & HIV-related sexual behaviors among adult who inject drugs: A prospective study. Drug & Alcohol Dependence, 42, 175-181.

Leal, J., Ziedonis, D., & Kosten, T. (1994). Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug & Alcohol Dependence, 35, 31-35.

Levy, A., Rittenhouse, P., Bonadonna, A., Alvarez-Sanz, M., Bethea, C. & Van der Kar, L. (1993). Repeated exposure to cocaine produces long-lasting deficits in the serotonergic stimulation of prolactin & renin, but not adrenocortotropin secretion. European Journal of Pharmacology, 241, 275-278.

Lindesmith Center. (1998). Research brief: Cocaine & Pregnancy. Http://www.lindesmith.org/cites_sources/brief12.html.

Louie, A.K., Lannon, R.A., Rutzick, E.A., Browne, D., Lewis, T.B., & Jones, R. (1996). Clinical features of cocaine-induced panic. Biological Psychiatry, 40, 938-940.

Lukas, S., Sholar, M., Fortin, M., Wines, J., & Mendelson, J. (in press). Sex differences in plasma cocaine levels & subjective effects after acute cocaine administration in human volunteers. Psychopharmacology.

Maher, L. (1996). Hidden in the light: Occupational norms among crack-using street-level sex workers. Journal of Drug Issues, 26(1), 143-173.

Majewska, M.D. (1996). Cocaine addiction as a neurological disorder: Implications for treatment. NIDA Research Monograph, 163, 1-26.

Marlatt, G.A. & Gordon, J.R. (Eds.). (1985). Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press.

Marlowe, D.B., Kirby, K.C., Bonieskie, L.M., Glass, D.J., Dodds, L.D., Husband, S.D., Platt, J.J., & Festinger, D.S. (1996). Assessment of coercive & noncoercive pressures to enter drug-abuse treatment. Drug & Alcohol Dependence, 42, 77-84.

Marlowe, D.B., Kirby, K.C., Festinger, D.S., Husband, S.D., & Platt, J.J. (1997). Impact of comorbid personality disorder & personality disorder symptoms on outcomes of behavioral treatment for cocaine dependence. Journal of Nervous & Mental Disease, 185 (8), 483-490.

Martin, K., Rogers, T., & Kavanaugh, A. (1995). Central nervous system angiopathy associated with cocaine abuse. The Journal of Rheumatology, 22, 780-782.

Mayes L., Bornstein M., Chawarska, K., & Granger R. (1995). Information processing & developmental assessments in 3-month-old infants exposed prenatally to cocaine. Pediatrics, 95(4), 539-45.

McCance, Elinore F. (1997). Overview of Potential Treatment Medications for Cocaine Dependence. In Betty Tai, Nora Chiang & Peter Bridge (Eds.) Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials. NIDA Research Monograph 175, US Department of Health & Human Services, Rockville Maryland.

McKay, J.R., Rutherford, M.J., Cacciola, J.S., Kabasakalian-McKay, R., & Alterman, A.I. (1996). Gender differences in the relapse experiences of cocaine patients. Journal of Nervous & Mental Disease, 184(10), 616-622.

McKenzie, D., (1997). Street Youth. in Canadian Profile: Alcohol, Tobacco & Other Drugs, Ottawa: Canadian Centre on Substance Abuse, 166-176.

McKenzie, D., & Single, E. (1997). Licit & Illicit Drugs. in Canadian Profile: Alcohol, Tobacco & Other Drugs, Ottawa: Canadian Centre on Substance Abuse, 92-131.

Mendelson, J.H., Teoh, S.K., Mello, N.K., & Ellingboe, J. (1992). Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion & mood states in man. Neuropsychopharmacology, 7, 157-162.

Merkel, P.A., Koroshetz, W.J., Irizarry, M.C., & Cudkowicz, M.E. (1995). Cocaine-associated cerebral vasculitis. Seminars in Arthritis & Rheumatism, 25(3), 172-183.

Middleton, R.M., & Kirkpatrick, M.B. (1993). Clinical Use of Cocaine. A review of the risks & benefits. Drug Safety, 9, 212-217.

Miller, N.S., & Gold, M.S. (1994). Dissociation of "conscious desire" (craving) from & relapse in alcohol & cocaine dependence. Annals of Clinical Psychiatry, 6(2), 99-106.

Miller, N.S., Gold, M.S., & Mahler, J.C. (1991). Violent behaviors associated with cocaine use: Possible pharmacological mechanisms. International Journal of the Addictions, 26(10), 1077-1088.

Miller, N. S., Summers, G. L., & Gold, M. S. (1993). Cocaine dependence: Alcohol & other drug dependence & withdrawal characteristics. Journal of Addictive Disease, 12(1), 25-35.

Mittenberg, W., & Motta, S. (1993). Effects of chronic cocaine abuse on memory & learning. Archives of Clinical Neuropsychology, 8, 477-483.

Moeller, F.G., Dougherty, D.M., Rustin, T., Swann, A.C., Allen, T.J., Shah, N., & Cherek, D.R. (1997). Antisocial personality disorder & aggression in recently abstinent cocaine dependent subjects. Drug & Alcohol Dependence, 44, 175-182.

Montoya, I.D., Levin, F.R., Fudala, P.J., & Gorelick, D.A. (1995). Double-blind comparison of carbamazepine & placebo for treatment of cocaine dependence. Drug & Alcohol Dependence, 38, 213-219.

Muller, R.B., & Boyle, J.S. (1996). "You don't ask for trouble": Women who do sex & drugs. Family Community Health, 19(3), 35-48.

Nademanee, K. (1992). Cardiovascular effects & toxicities of cocaine. Journal of Addictive Diseases, 11(4), 71-82.

National Institute on Drug Abuse. (1996). Cocaine affects men & women differently, NIDA study shows. NIDA Notes.

National Institute on Drug Abuse. (1998). A cognitive behavioural Approach: Treating Cocaine Addiction. Manual NCADI#BKD254 GPO# 017-024-01615-2.

National Institute on Drug Abuse. (1998). A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction. Manual NCAD# BKD255 GPO#017-024-01616-1.

National Institute on Drug Abuse. (1998). Cocaine Abuse.

National Institute on Drug Abuse (1998). Study Sheds New Light on the State of Drug Abuse Treatment Nationwide. NIDA Notes, Vol. 12, #5. Noldy, N.E., & Carlen, P.L. (1997). Event-related potential changes in cocaine withdrawal: Evidence for long-term cognitive effects. Neuropsychobiology, 36, 53-56.

Nunes, E.V., McGrath, P.J., Quitkin, F.M., Ocepek-Welikson, K., Stewart, J.W., Koenig, T., Wager, S., & Klein, D.F. (1995). Imipramine treatment of cocaine abuse: Possible boundaries of efficacy. Drug & Alcohol Dependence, 39, 185-195.

Oliveto, A., Kosten, T.R., Schottenfeld, R., Falcioni, J., & Ziedonis, D. (1995). Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. Journal of Substance Abuse Treatment, 12, 423-428.

O'Neill, W.M. (1994). The cogntive & psychomotor effects of opiate drugs in cancer pain management. Cancer Surveys, 21, 67-84.

Pagliaro, L.A., & Pagliaro, A.M. (1993). The phenomenon on abusable psychotropic use among North American youth. Journal of Clinical Pharmacology, 33, 676-690.

Patrick, D.M., Strathdee, S.A., Archibald, C.P., Ofner, M., Craib, K.J.P., Cornelisse, P.G.A., Schechter, M.T., Rekart, M.L., & O'Shaughnessy, M.V. (1997). Determinants of HIV seroconversion in people who inject drugs during a period of rising prevalence in Vancouver. International Journal of STD & AIDS, 8, 437-445.

Pickering, H., & Stimson, G.V. (1994). Prevalence & demographic factors of stimulant use. Addiction, 89, 1385-1389.

Poulin, C. (1997). Canadian Community Epidemiology Network on Drug Use Inaugural National Report.

Poulin, C., Single, E., & Fralick, P. (1999) Canadian Community Epidemiology Network on Drug Use (CCENDU). Second National Report, 1999.

Powis, B., Griffiths, P., Gossop, M., & Strang, B. (1996). The differences between male & female drug users: community samples of heroin cocaine users compared. Substance Use & Misuse 1(5), 529-543.

Prenndergast, M. L. (1994). Substance use & abuse among college students: A review of recent literature. College Health, 43, 99-113.

Prince Edward Island. 1996. Student Drug Use Survey: Atlantic Provinces Technical Report. Charlottetown: Prince Edward Island.

Raskin, H., & Bates M., (1993). Self-attributed consequences of cocaine use. The International Journal of the Addictions, 28(3), 187-209.

Regalado, M.G., Schechtman, V.L., Del Angel, A.P., & Bean, X.B. (1996). Cardiac & respiratory patterns during sleep in cocaine-exposed neonates. Early Human Development, 44, 187-200.

Richard, A.J., Montoya, I.D., Nelson, R., & Spence, R.T. (1995). Effectiveness of adjunct therapies in crack cocaine treatment. Journal of Substance Abuse Treatment, 12, 401-413.

Roll, J.M., Higgins, S.T., Budney, A.J., Bickel, W.K., & Badger, G.J. (1996). A comparison of cocaine-dependent cigarette smokers & non-smokers on demographics, drug use, & other characteristics. Drug & Alcohol Dependence, 40, 195-201.

Rosen, M.I., & Kosten, T. (1992). Cocaine-associated panic attacks in methadone-maintained patients. American Journal of Drug & Alcohol Abuse, 18, 57-62.

Rosenblum, Andrew, Magura, Stephen, Palij, Michael, Foote, Jeffery, Handelsman, Leonard & Stimmel, Barry (1999). Enhanced treatment outcomes for cocaine-using methadone patients. Drug and Alcohol Dependence, 54, 207-218.

Rosse, R.B., Alim, T.N., Johri, S.K., Hess, A.L., & Deutsch, S.I. (1995). Anxiety & pupil reactivity in cocaine dependent subjects endorsing cocaine-induced paranoia: preliminary report. Addiction, 90, 981-984.

Rosse, R.B., Fay-McCarthy, M., Collins, J.P., Alim, T.N., & Deutsch, S.I., (1994). The relationship between cocaine-induced paranoia & compulsive foraging: A preliminary report. Addiction, 89, 1097-1104.

Rosselli, M., & Ardila, A. (1996). Cognitive effects of cocaine & polydrug abuse. Journal of Clinical & Experimental Neuropsychology, 18, 122-135.

Rothman, R.B. (1990). High affinity dopamine re-uptake inhibitors as potential cocaine antagonists: A strategy for drug development. Life Sciences, 46, PL-17 PL-21.

Roy, M., Smelson, D., & Roy, A. (1997). Longitudinal study of blue cone retinal function in cocaine-withdrawn patients. Biological Psychiatry, 41, 252-253.

Saladin, M.E., Brady, K.T., Dansky, B.S., & Kilpatrick, D.G. (1995). Understanding co-morbidity between PTSD substance use disorder: Two preliminary investigations. Addictive Behaviors, 20(5), 643-655.

Saterlee, S., Seiby, J., & Charney, D. (1991). Prolonged cocaine psychosis implies underlying major pyschopathology. Journal of Clinical Psychiatry 52(8), 349-350.

Schneider, R., Mittelmeier, C., & Gadish, D. (1996). Day versus inpatient treatment for cocaine dependence: An experimental comparison. The Journal of Mental Health Administration, 23, 234-245.

Schumacher, J.E., Milby, J.B., Caldwell, E., Raczynski, J., Engle, M., Michael, M., & Carr, J. (1995). Treatment outcome as a function of treatment attendance with homeless persons abusing cocaine. Journal of Addictive Diseases, 14(4), 73-85.

Schwartz, R.H., Luxenberg, M.G., & Hoffman, N.G. (1991). "Crack" use by American middle-class adolescent polydrug abusers. Pediatrics, 118, 150-155.

Sevy, S., Kay, S.R., Opler, L.A., & van Praag, H.M. (1990). Significance of cocaine history in schizophrenia. Journal of Nervous & Mental Disease, 178(10), 642-648.

Shah, S.M., Shapshak, P., Rivers, J.E., Sterwart, R.V., Weatherby, N.L., Xin, K.Q., Page, J.B., Chitwood, D.D., Mash, D.C., Vlahov, D., & McCoy, C.B. (1996). Detection of HIV-1 DNA in needle/syringes, paraphernalia, & washes from shooting galleries in Miami: A preliminary report. Journal of Acquired Immune Deficiency Syndromes, 11(3), 301-306.

Slusher, B.S., Tiffany, C.W., Olkowski, J.L., & Jackson, P.F. (1997). Use of identical assay conditions for cocaine analog binding & dopamine uptake to identify potential cocaine antagonists. Drug & Alcohol Dependence, 48, 43-50.

Smart, R.G. (1991). Crack cocaine use: A review of prevalence & adverse effects. American Journal of Drug & Alcohol Abuse, 17(1), 13-26.

Smart, R., Adlaf, E.M., Walsh, G.W., & Zdanowicz, Y.M. (1992). Drifting & doing: Changes in drug use among Toronto street use, 1990-92. Toronto: Addiction Research Foundation.

Smith, G.A., Strausbaugh, S.D., Harbeck-Weber, C., Shields, B.J., Powere, J.D., & Hackenberg, D. (1996). Comparison of topical anesthetics without cocaine to tetracaine-adrenaline-cocaine & lidocaine infiltration during repair of lacerations: Bupivacaine-norepinephrine is an effective new topical anesthetic agent. Pediatrics, 97(3), 301-307.

Smokowski, P.R., & Wodarski, J. S. (1998) Cognitive Behavioural Treatment for Cocaine Addiction: Clinical Effectiveness & Practitioner Guidelines. Journal of Applied Social Sciences, 23(1), 23-32.

Sorenson J., & Lurie, P. (1993). Do NEP's act as bridges to public health services? Chapter 7 in P. Lurie & J. Reingold (Eds.), The public health impact of needle exchange programs in the United States & abroad, Volume I. School of Public Health, University of California, Berkeley, California, & Institute for Health Policy Studies, University of California, San Francisco, California.

Spealman, R.D., Bergman, B.K., Madras, B.K., Kamien, J.B., & Melia, K.F. (1992). Role of D1 & D2 dopamine receptors in the behavioral effects of cocaine. Neurochemical International, 20 (supplemental), 147s-152s.

Spunt, B., Brownstein, H.H., Crimmins, S.M., & Langley, S. (1996). Drugs & homicide by women. Substance Use & Misuse, 31(7), 825-845.

Sterk-Elifson, C. (1996). Just for fun?: Cocaine use among middle-class women. Journal of Drug Issues, 26(1), 63-76.

Sterling, R.C., Gottheil, E., Weinstein, S.P., Lundy, A., & Serota, R.D. (1996). Learned helplessness & cocaine dependence: An investigation. Journal of Addictive Disease, 15(2), 13-24.

Stine, S.M., Krystal, J.H., Kosten, T.R., & Charney, D.S. (1995). Mazindol treatment for cocaine dependence. Drug & Alcohol Dependence, 39, 245-252.

Stocker, S. (1997). Compounds show strong promise for treating cocaine addiction. NIDA Notes, May/June, 1-4.

Strain, E.C., Stitzer, M.L., Liebson, I.A., & Bigelow, G.E. (1994). Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users. Psychopharmacology, 116, 401-406.

Strathdee, S.A., Patrick, D.M., Archibald, C.P., Ofner, M., Cornelisse, P.G., Rekart, M.L., Schechter, M.T., & O'Shaughnessy, M. (1997). Social determinants predict needle-sharing behavior among people who inject drugs in Vancouver, Canada. Addiction 92, 1339-1347.

Strathdee, S.A., Patrick, D.M., Currie, S.L., Cornelisse, P.G., Rekart, M.L., Montaner, J.S.,

Schechter, M.T., & O'Shaughnessy, M. (1997). Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS, 11, 59-65.

Strauss, R.S. (1997). Effects of the intrauterine environment on childhood growth. British Medical Bulletin, 53, 81-95.

Strickland, T.L., & Stein, R. (1995). Cocaine-induced cerebrovascular impairment: Challenges to neuropsychological assessment. Neuropsychology Review, 5, 69-79.

Swadi, H. (1992). Psychiatric symptoms in drug-abusing adolescents. Drug & Alcohol Dependence, 31, 77-83.

Tardiff, K., Marzuk, P.M., Leon, A.C., Portera, L., & Weiner, C. (1997). Violence by patients admitted to a private psychiatric hospital. American Journal of Psychiatry, 154, 88-93.

Tashkin, D.P., Gorelick, D., Khalsa, M., Simmons, M., & Chang, P. (1992). Respiratory effects of cocaine freebasing among habitual cocaine users. Journal of Addictive Diseases, 11(4) 59-70.

Thompson, D.F. (1992). Amantadine in the treatment of cocaine withdrawal. The Annals of Pharmacotherapy, 26, 933-934.

Treatment Outcome Working Group. (1996). Treatment Protocol Effectiveness Study. Journal of Substance Abuse Treatment, 13, 295-319.

Turbat-Herrera, E.A. (1994). Myoglobinuric acute renal failure associated with cocaine use. Unstructural Pathology, 18, 127-131.

Vogel, G. (1997). Cocaine wreaks subtle damage on developing brains. Science, 278, 38-39.

Volkow, N.D., Wang, G.J., Fiscman, M.W., Foltin, R.W., Fowler, J.S., Abumrad, N.N., Vitkun, S., Logan, J., Gatley, S.J., Pappas, N., Hitzemann, R., & Shea, C.E. (1997). Relationship between subjective effects of cocaine & dopamine transporter occupancy. Nature, 386, 827-830.

Waldorf, D., & Murphy, S. (1995). Perceived risk & criminal justice pressures on middle-class cocaine sellers. Journal of Drug Issues, 25(1), 11-32.

Walsh, S.L., Preston, K.L., Sullivan, J.T., Fromme, R., & Bigelow, G.E. (1994). Fluoxetine alters the effects of intravenous cocaine in humans. Journal of Clinical Psychopharmacology, 14, 396-407.

Warner, E.A. (1993). Cocaine abuse. Annals of Internal Medicine, 119(3), 226-235.

Washburn, A.M., Batki, S.L., Delucci, K., Murphy, J., Jones, T.A., & Nanda, N. (1994) Predictors of outcome in a clinical trial of fluoxetine. In L.S. Harris, (Ed.) Problems of Drug Dependence, 1993: Proceedings of the 55th Annual Scientific Meeting; The College on Problems of Drug Dependence Inc., National Institute of Drug Abuse Monograph 141, NIH Pub. No. 94-3749, Washington, D.C., Supt. of Docs., U.S. Govt. Print. Off. 1994, p 139.

Watters, J.K. (1994). Trends in risk behavior & HIV seroprevelance in heterosexual who inject drugs in San Francisco, 1986-1992. Journal of Acquired Immune Deficiency Syndromes, 7, 1276-1281.

Weiss, R.D., Griffin, M.L., Najavits, L.M., Hufford, C., Kogan, J., Thompson, H.J., Albeck, J.H., Bishop, S., Daley, D.C., Mercer, D., & Siqueland, L. (1996). Self-help activities in cocaine-dependent patients entering treatment: Results from the NIDA collaborative cocaine treatment study. Drug & Alcohol Dependence, 43, 79-86.

Weiss, R.D., Mirin, S.M., Griffin, M.L., Gunderson, J.G., & Hufford, C. (1993). Personality disorders in cocaine dependence. Comprehensive Psychiatry, 34(3), 145-149.

Wells, Elizabeth A., (1994). Outpatient Treatment of Cocaine Abuse: A Controlled Comparison of Relapse Prevention and Twelve-Steps Approaches. American Journal of Drugs and Alcohol Abuse. 20(1/2), 1-17.

Wetli, C.V. (1987). Fetal cocaine intoxication. The American Journal of Forensic Medicine & Psychopathology, 8(1), 1-2.

Wetli, C.V., Mash, D., & Karch, S.B. (1996). Cocaine-associated agitated delirium & the neuroleptic malignant syndrome. American Journal of Emergency Medicine, 14, 425-428.

White, H.R., & Bates, M.E. (1993). Self-attributed consequences of cocaine use. International Journal of the Addictions, 28(3), 187-209.

Wilkins, J.N. (1992). Brain, lung, & cardiovascular interactions with cocaine & cocaine-induced catecholamine effects. Journal of Addictive Diseases, 1992; 11(4), 9-19.

Williamson, S., Gossop, M., Powis, B., Griffiths, P., Fountain, J., & Strang, J. (1997). Adverse effects of stimulant drugs in a community sample of drug users. Drug & Alcohol Dependence, 44, 87-94.

Wolff, L., & Reingold, B. (1994). "Drug Use & Crime." Juristat Service Bulletin 14(6). Ottawa: Statistics Canada.

World Health Organization. (1998). WHO Cocaine Project. Gopher://gopher.who.ch:70/00/anonymousftp/programme/psa/2i3coca.txt.

Zanis, D.A., Cohen, E., Meyers, K., & Cnaan, R.A. (1997). HIV risks among homeless men differentiated by cocaine use & psychiatric distress. Addictive Behaviors, 22, 287-292.

Zuckerman, B., & Frank, D.A. (1994). Prenatal cocaine exposure: Nine years later. The Journal of Pediatrics, 124, 731-733.